Insiders · ATRA

ATRA insider transactions

Atara Biotherapeutics Inc. (ATRA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ATRA

• 14d
  President and CEO Nguyen Anhco sold $47,845 worth of shares (5,241 units at $9.13), decreasing direct ownership by 4% to 137,837 units (SEC Form 4) (tax liability)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 14d
  Chief Accounting Officer Grant-Huerta Yanina sold $22,036 worth of shares (2,414 units at $9.13), decreasing direct ownership by 5% to 49,636 units (SEC Form 4) to cover withholding tax

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 22d
  Large owner Panacea Innovation Ltd sold $3,165,021 worth of shares (313,446 units at $10.10) (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 23d
  Large owner Ecor1 Capital, Llc bought $4,744,255 worth of shares (507,407 units at $9.35) (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 23d
  New insider Ecor1 Capital, Llc claimed ownership of 1,044,593 shares (SEC Form 3)

  3 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 76d
  SEC Form 4 filed by Panacea Innovation Ltd

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 84d
  SEC Form 4 filed by Atara Biotherapeutics Inc.

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 84d
  SEC Form 4 filed by Atara Biotherapeutics Inc.

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 91d
  Chief Accounting Officer Grant-Huerta Yanina sold $10,691 worth of shares (2,104 units at $5.08), decreasing direct ownership by 6% to 31,750 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 91d
  President and CEO Nguyen Anhco sold $15,237 worth of shares (2,996 units at $5.09), decreasing direct ownership by 5% to 61,978 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 139d
  Large owner Panacea Innovation Ltd sold $489,019 worth of shares (80,554 units at $6.07) (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 184d
  Large owner Panacea Innovation Ltd exercised 48,737 shares at a strike of $0.00 and covered exercise/tax liability with 1 shares (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 196d
  President and CEO Nguyen Anhco sold $38,437 worth of shares (2,915 units at $13.19), decreasing direct ownership by 4% to 64,974 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 196d
  Chief Accounting Officer Grant-Huerta Yanina sold $23,788 worth of shares (1,804 units at $13.19), decreasing direct ownership by 5% to 33,454 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 287d
  President and CEO Nguyen Anhco sold $34,360 worth of shares (2,958 units at $11.62), decreasing direct ownership by 4% to 67,889 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 287d
  Chief Accounting Officer Grant-Huerta Yanina sold $21,009 worth of shares (1,809 units at $11.61), decreasing direct ownership by 5% to 35,258 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 287d
  Large owner Panacea Innovation Ltd bought $670,422 worth of shares (55,000 units at $12.19) (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 317d
  Large owner Panacea Innovation Ltd bought $186,372 worth of shares (19,335 units at $9.64) (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 355d
  Director Gallagher Carol Giltner was granted 7,828 shares, increasing direct ownership by 31% to 33,012 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 355d
  Director Fust Matthew K was granted 7,828 shares, increasing direct ownership by 76% to 18,188 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 355d
  Director Touchon Pascal was granted 7,828 shares, increasing direct ownership by 11% to 77,955 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 355d
  Director Roncarolo Maria Grazia was granted 7,828 shares, increasing direct ownership by 82% to 17,368 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 355d
  Director Mallik Ameet was granted 7,828 shares, increasing direct ownership by 86% to 16,928 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 355d
  Director Heiden William K was granted 7,828 shares, increasing direct ownership by 55% to 22,188 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 376d
  SEC Form 3 filed by new insider Subramanian Nachiappan

  3 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 376d
  New insider Redmile Group, Llc claimed ownership of 441,701 shares (SEC Form 3)

  3 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 378d
  New insider Panacea Innovation Ltd claimed ownership of 1,330,665 shares (SEC Form 3)

  3 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 379d
  Chief Accounting Officer Grant-Huerta Yanina sold $15,000 worth of shares (2,218 units at $6.76), decreasing direct ownership by 6% to 37,067 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 379d
  President and CEO Nguyen Anhco sold $22,156 worth of shares (3,276 units at $6.76), decreasing direct ownership by 4% to 70,847 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 383d
  Director Adiumentum Capital Fund I Lp was granted 75,572 shares (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 418d
  New insider Grant-Huerta Yanina claimed ownership of 39,285 shares (SEC Form 3)

  3 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 426d
  SEC Form 4 filed by Former EVP, CFO & COO Hyllengren Eric J

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 455d
  President and CEO Nguyen Anhco sold $23,307 worth of shares (3,331 units at $7.00), decreasing direct ownership by 4% to 74,123 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 455d
  EVP, CFO and COO Hyllengren Eric J sold $8,473 worth of shares (1,211 units at $7.00), decreasing direct ownership by 2% to 56,231 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 455d
  EVP, Chief Regulatory Officer Henrich Jill sold $7,410 worth of shares (1,059 units at $7.00), decreasing direct ownership by 5% to 18,679 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 490d
  EVP, CFO and COO Hyllengren Eric J was granted 34,050 shares, increasing direct ownership by 146% to 57,442 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 559d
  EVP, Chief Regulatory Officer Henrich Jill sold $11,198 worth of shares (1,000 units at $11.20), decreasing direct ownership by 5% to 19,378 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 559d
  EVP, CFO and COO Hyllengren Eric J sold $15,274 worth of shares (1,364 units at $11.20), decreasing direct ownership by 6% to 23,392 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 559d
  President and CEO Nguyen Anhco sold $18,633 worth of shares (1,664 units at $11.20), decreasing direct ownership by 2% to 77,454 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 630d
  President and CEO Nguyen Anhco was granted 45,000 shares, increasing direct ownership by 132% to 79,118 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 635d
  New insider Adiumentum Capital Fund I Lp claimed ownership of 1,133,823 shares (SEC Form 3)

  3 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 652d
  President and CEO Touchon Pascal sold $20,139 worth of shares (3,038 units at $6.63), decreasing direct ownership by 4% to 70,127 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 652d
  EVP, Chief Sci. & Tech Officer Nguyen Anhco sold $12,072 worth of shares (1,821 units at $6.63), decreasing direct ownership by 5% to 34,118 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 652d
  EVP, Chief Legal Officer Murugan Amar sold $7,677 worth of shares (1,158 units at $6.63), decreasing direct ownership by 4% to 26,827 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 652d
  EVP, CFO Hyllengren Eric J sold $7,093 worth of shares (1,070 units at $6.63), decreasing direct ownership by 4% to 24,756 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 652d
  EVP, Global Head RA & Quality Henrich Jill sold $6,384 worth of shares (963 units at $6.63), decreasing direct ownership by 5% to 20,378 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 658d
  SEC Form 4 filed by President and CEO Touchon Pascal

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 743d
  Touchon Pascal sold $50,289 worth of shares (81,506 units at $0.62), decreasing direct ownership by 4% to 1,829,146 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 743d
  Nguyen Anhco sold $26,469 worth of shares (42,899 units at $0.62), decreasing direct ownership by 5% to 898,498 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 743d
  Murugan Amar sold $19,991 worth of shares (32,401 units at $0.62), decreasing direct ownership by 4% to 695,120 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 743d
  Hyllengren Eric J sold $17,676 worth of shares (28,648 units at $0.62), decreasing direct ownership by 4% to 645,671 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 743d
  Henrich Jill sold $15,888 worth of shares (25,750 units at $0.62), decreasing direct ownership by 5% to 529,251 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 792d
  Fust Matthew K was granted 150,000 shares, increasing direct ownership by 138% to 259,000 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 792d
  Heiden William K was granted 150,000 shares, increasing direct ownership by 72% to 359,000 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 792d
  Roncarolo Maria Grazia was granted 150,000 shares, increasing direct ownership by 169% to 238,500 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 792d
  Gallagher Carol Giltner was granted 150,000 shares, increasing direct ownership by 31% to 629,608 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 792d
  Mallik Ameet was granted 150,000 shares, increasing direct ownership by 194% to 227,500 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 818d
  Murugan Amar sold $7,232 worth of shares (10,044 units at $0.72), decreasing direct ownership by 1% to 727,521 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 818d
  Nguyen Anhco sold $7,737 worth of shares (10,746 units at $0.72), decreasing direct ownership by 1% to 941,397 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)
• 818d
  Touchon Pascal sold $17,888 worth of shares (24,844 units at $0.72), decreasing direct ownership by 1% to 1,910,652 units (SEC Form 4)

  4 - Atara Biotherapeutics, Inc. (0001604464) (Issuer)